I am Greek and have thalassemia minor. In general, my red blood cells are much smaller than typical ones, and my iron content ...

Sleep issues are common with an autism diagnosis. Studies suggest that well over half of all autistic people, adults as well as children, have significant sleep issues. These sleep issues can be ...

Since the caffeine effect lingers longer than normal, you may experience heightened symptoms like insomnia, restlessness, or ...

Struggling to sleep during the winter? New York respiratory therapist Fernanda Fanek has several free and easy tips for better slumber. Courtesy of Northwell Health So much for a “long winter ...

Caroline Igo (she/her/hers) is a wellness editor and holds Sleep Science Coach and Stress Management certificates from the Spencer Institute. She received her bachelor's degree in creative writing ...

Recent scientific research has revealed the complex relationship between magnesium glycinate and sleep patterns. This particular form of magnesium has gained attention in the scientific community ...

Some individuals may find themselves frequently waking up at four o'clock in the morning, and there could be a valid reason for these sleep interruptions. Do you often find yourself wide awake at ...

Short sleepers cruise by on four to six hours a night and don’t seem to suffer ill effects Marla Broadfoot, Knowable Magazine Some people are genetically built to require less sleep than the ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Amitriptyline hydrochloride is under clinical development by AlgoTherapeutix and currently in Phase II for Erythromelalgia. According to GlobalData, Phase II drugs for Erythromelalgia does not have ...

While most of us know that snoozing for an average of eight hours each night is the sweet spot for healthy sleep, surveys reveal that as many as 35% of us aren't getting the sleep we need.

Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when ...